ZA974366B - Potassium, sodium and tris oxaprozin salt pharmaceutical formulations. - Google Patents
Potassium, sodium and tris oxaprozin salt pharmaceutical formulations.Info
- Publication number
- ZA974366B ZA974366B ZA9704366A ZA974366A ZA974366B ZA 974366 B ZA974366 B ZA 974366B ZA 9704366 A ZA9704366 A ZA 9704366A ZA 974366 A ZA974366 A ZA 974366A ZA 974366 B ZA974366 B ZA 974366B
- Authority
- ZA
- South Africa
- Prior art keywords
- sodium
- potassium
- pharmaceutical formulations
- salt pharmaceutical
- tris
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1903396P | 1996-05-20 | 1996-05-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA974366B true ZA974366B (en) | 1998-05-20 |
Family
ID=21791076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9704366A ZA974366B (en) | 1996-05-20 | 1997-05-20 | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations. |
Country Status (20)
Country | Link |
---|---|
US (1) | US6030643A (fr) |
EP (1) | EP0901372B1 (fr) |
JP (1) | JP4185974B2 (fr) |
KR (1) | KR20000015865A (fr) |
CN (1) | CN1129429C (fr) |
AT (1) | ATE299699T1 (fr) |
AU (1) | AU718030B2 (fr) |
BR (1) | BR9710448A (fr) |
CA (1) | CA2255064C (fr) |
CZ (1) | CZ370298A3 (fr) |
DE (1) | DE69733752T2 (fr) |
ES (1) | ES2248850T3 (fr) |
IL (1) | IL126998A (fr) |
NO (1) | NO985414L (fr) |
NZ (1) | NZ332861A (fr) |
PL (1) | PL330145A1 (fr) |
RU (1) | RU2197244C2 (fr) |
TW (1) | TW586929B (fr) |
WO (1) | WO1997044022A1 (fr) |
ZA (1) | ZA974366B (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001022939A1 (fr) * | 1999-09-29 | 2001-04-05 | Fmc Corporation | Granulations par cellulose hydrolyzee de sels de medicaments |
US6497157B1 (en) * | 1999-11-29 | 2002-12-24 | Distek, Inc. | Intrinsic dissolution apparatus with stationary sample holder |
FR2828810B1 (fr) * | 2001-08-27 | 2005-10-07 | Lvmh Rech | Composition cosmetique a effet tenseur contenant un polymere d'origine naturelle et un agent hydratant polyhydroxyle |
KR100574554B1 (ko) * | 2004-05-28 | 2006-04-27 | 한미약품 주식회사 | 니아신의 경구투여용 서방성 조성물 |
AU2006228869A1 (en) * | 2005-03-30 | 2006-10-05 | Astion Pharma A/S | Oxaprozin or a closely related compound for the treatment of eczema |
US20060229347A1 (en) * | 2005-03-30 | 2006-10-12 | Astion Development A/S | Treatment of eczemas |
WO2006130726A2 (fr) * | 2005-06-01 | 2006-12-07 | Teva Pharmaceutical Industries, Ltd. | Utilisation du ladostigil pour traiter la sclerose en plaques |
TW200836774A (en) * | 2007-02-01 | 2008-09-16 | Takeda Pharmaceutical | Solid preparation |
EA201491749A1 (ru) * | 2012-03-22 | 2015-01-30 | ТРАНСТЕК ФАРМА, ЭлЭлСи | Трис-(гидроксиметил)аминометановые соли низкомолекулярного агониста glp1r, их фармацевтические композиции и применение |
EP3275433A1 (fr) | 2016-07-29 | 2018-01-31 | Som Innovation Biotech S.L. | Composition à libération prolongée comprenant du tolcapone micronisé |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1206403A (en) * | 1966-12-15 | 1970-09-23 | Wyeth John & Brother Ltd | Oxazoles |
US3578671A (en) * | 1967-11-06 | 1971-05-11 | Wyeth John & Brother Ltd | Oxazoles |
US3998815A (en) * | 1974-06-24 | 1976-12-21 | Interx Research Corporation | 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts |
US4190584A (en) * | 1976-08-13 | 1980-02-26 | John Wyeth & Brother Limited | Process for preparing oxazoles |
GB2097389B (en) * | 1981-04-28 | 1984-11-28 | Wyeth John & Brother Ltd | Oxazole derivative |
IE52909B1 (en) * | 1981-04-28 | 1988-04-13 | Wyeth John & Brother Ltd | Oxazole derivatives |
US4385049A (en) * | 1981-05-12 | 1983-05-24 | K-V Pharmaceutical Company | Stable high internal phase ratio topical emulsions |
US4599359A (en) * | 1982-12-09 | 1986-07-08 | Stephen A. Cooper | Hydroxyzine-containing analgesic combinations |
GB8329326D0 (en) * | 1983-11-03 | 1983-12-07 | Wyeth John & Brother Ltd | Oxazole derivatives |
IT1204751B (it) * | 1986-01-03 | 1989-03-10 | Therapicon Srl | Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico,loro preparazione ed utilizzo in composizioni farmaceutiche |
GB8630273D0 (en) * | 1986-12-18 | 1987-01-28 | Til Medical Ltd | Pharmaceutical delivery systems |
US5059626A (en) * | 1988-07-25 | 1991-10-22 | Applied Analytical Industries, Inc. | Liquid oral pharmaceutical compositions of non-steroidal anti-inflammatory drugs |
WO1992007561A1 (fr) * | 1990-10-30 | 1992-05-14 | Ss Pharmaceutical Co., Ltd. | Preparation d'un gel anti-inflammatoire et analgesique |
CA2170485C (fr) * | 1993-09-07 | 2000-11-07 | Sekhar Mitra | Compositions renfermant un sel d'acide propionique d'amino-acide, agents anti-inflammatoires non steroidiques utilises avec la cafeine |
AU7604094A (en) * | 1993-09-07 | 1995-03-27 | Procter & Gamble Company, The | Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
-
1997
- 1997-05-14 DE DE69733752T patent/DE69733752T2/de not_active Expired - Lifetime
- 1997-05-14 NZ NZ332861A patent/NZ332861A/xx unknown
- 1997-05-14 WO PCT/US1997/007637 patent/WO1997044022A1/fr not_active Application Discontinuation
- 1997-05-14 KR KR1019980709415A patent/KR20000015865A/ko not_active Application Discontinuation
- 1997-05-14 ES ES97925466T patent/ES2248850T3/es not_active Expired - Lifetime
- 1997-05-14 CA CA002255064A patent/CA2255064C/fr not_active Expired - Fee Related
- 1997-05-14 JP JP54242197A patent/JP4185974B2/ja not_active Expired - Fee Related
- 1997-05-14 AT AT97925466T patent/ATE299699T1/de not_active IP Right Cessation
- 1997-05-14 RU RU98123101/14A patent/RU2197244C2/ru not_active IP Right Cessation
- 1997-05-14 CN CN97196583A patent/CN1129429C/zh not_active Expired - Fee Related
- 1997-05-14 CZ CZ983702A patent/CZ370298A3/cs unknown
- 1997-05-14 IL IL12699897A patent/IL126998A/xx not_active IP Right Cessation
- 1997-05-14 AU AU30597/97A patent/AU718030B2/en not_active Ceased
- 1997-05-14 EP EP97925466A patent/EP0901372B1/fr not_active Expired - Lifetime
- 1997-05-14 PL PL97330145A patent/PL330145A1/xx unknown
- 1997-05-14 BR BR9710448A patent/BR9710448A/pt not_active Application Discontinuation
- 1997-05-16 US US08/857,999 patent/US6030643A/en not_active Expired - Fee Related
- 1997-05-20 TW TW086106729A patent/TW586929B/zh not_active IP Right Cessation
- 1997-05-20 ZA ZA9704366A patent/ZA974366B/xx unknown
-
1998
- 1998-11-20 NO NO985414A patent/NO985414L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1129429C (zh) | 2003-12-03 |
CZ370298A3 (cs) | 1999-05-12 |
WO1997044022A1 (fr) | 1997-11-27 |
ATE299699T1 (de) | 2005-08-15 |
BR9710448A (pt) | 1999-08-17 |
NO985414L (no) | 1999-01-19 |
RU2197244C2 (ru) | 2003-01-27 |
US6030643A (en) | 2000-02-29 |
NZ332861A (en) | 2000-08-25 |
IL126998A0 (en) | 1999-09-22 |
EP0901372B1 (fr) | 2005-07-20 |
CA2255064A1 (fr) | 1997-11-27 |
CA2255064C (fr) | 2006-10-10 |
EP0901372A1 (fr) | 1999-03-17 |
JP2001503734A (ja) | 2001-03-21 |
KR20000015865A (ko) | 2000-03-15 |
DE69733752T2 (de) | 2006-06-01 |
JP4185974B2 (ja) | 2008-11-26 |
AU3059797A (en) | 1997-12-09 |
ES2248850T3 (es) | 2006-03-16 |
NO985414D0 (no) | 1998-11-20 |
TW586929B (en) | 2004-05-11 |
AU718030B2 (en) | 2000-04-06 |
IL126998A (en) | 2003-12-10 |
DE69733752D1 (de) | 2005-08-25 |
PL330145A1 (en) | 1999-04-26 |
CN1225580A (zh) | 1999-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA199800772A1 (ru) | Производные 6-фенилпиридил-2-амина | |
MX9705569A (es) | Inhibidores de adhesion celular. | |
SG158733A1 (en) | Cell adhesion inhibitors | |
FI962154A (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
MX9800348A (es) | Inhibidores de adhesion celular. | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
ZA943744B (en) | Therapeutic substituted guanidines | |
GB2288732B (en) | Pharmaceutical compositions | |
DE69905170D1 (en) | Thiazolopyrimidinderivate | |
HK1025737A1 (en) | Treatment of multiple sclerosis through ingestion of copolymer-1 | |
IL127918A0 (en) | Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations | |
YU13301A (sh) | Muskarinski agonisti i antagonisti | |
ZA974366B (en) | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations. | |
BG102250A (en) | The use of marigold-extracted glycosides for the treatment of psoriasis | |
EP1032556A4 (fr) | Composes pharmaceutiquement actifs et procedes d'utilisation | |
NZ330944A (en) | Peptide derivatives | |
PL316656A1 (en) | Free halophantrin base for use in treating marsh-fever and compositions containing same | |
MXPA94009086A (es) | Guanidinas sustituidas terapeuticas. | |
MX9403088A (es) | Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso. | |
IL111805A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of aphthae | |
IL111804A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of constipation | |
NZ217356A (en) | Benzamide derivatives and pharmaceutical compositions | |
MD457G2 (ro) | Derivaţi noi de naftiridină, procedeu de preparare a lor, compoziţii farmaceutice care le conţin, utilizarea lor ca medicamente de antireproducere | |
GB9921985D0 (en) | Medicaments containing pantothenic acid | |
MX9802809A (es) | Ureasa para el tratamiento de infecciones de helicobacter pylori. |